| Literature DB >> 32634771 |
Al B Benson1, Alan P Venook2, Mahmoud M Al-Hawary3, Mustafa A Arain2, Yi-Jen Chen4, Kristen K Ciombor5, Stacey Cohen6, Harry S Cooper7, Dustin Deming8, Ignacio Garrido-Laguna9, Jean L Grem10, Andrew Gunn11, Sarah Hoffe12, Joleen Hubbard13, Steven Hunt14, Natalie Kirilcuk15, Smitha Krishnamurthi16, Wells A Messersmith17, Jeffrey Meyerhardt18, Eric D Miller19, Mary F Mulcahy1, Steven Nurkin20, Michael J Overman21, Aparna Parikh22, Hitendra Patel23, Katrina Pedersen14, Leonard Saltz24, Charles Schneider25, David Shibata26, John M Skibber21, Constantinos T Sofocleous24, Elena M Stoffel3, Eden Stotsky-Himelfarb27, Christopher G Willett28, Alyse Johnson-Chilla29, Lisa A Gurski29.
Abstract
The NCCN Guidelines for Rectal Cancer provide recommendations for the diagnosis, evaluation, treatment, and follow-up of patients with rectal cancer. These NCCN Guidelines Insights summarize the panel discussion behind recent important updates to the guidelines. These updates include clarifying the definition of rectum and differentiating the rectum from the sigmoid colon; the total neoadjuvant therapy approach for localized rectal cancer; and biomarker-targeted therapy for metastatic colorectal cancer, with a focus on new treatment options for patients with BRAF V600E- or HER2 amplification-positive disease.Entities:
Year: 2020 PMID： 32634771 DOI： 10.6004/jnccn.2020.0032
Source DB: PubMed Journal: J Natl Compr Canc Netw ISSN： 1540-1405 Impact factor: 11.908